Internal Medicine, Rheumatology · Jacksonville, FL
NPI
1619098746
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
4205 Belfort Road, Suite 2005
Jacksonville, FL, 32216
Phone (904) 296-5870
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
1,107 services
Medicare patients, 2024
341
Average age 72
Drug cost, 2024
$6.4M
3,750 prescriptions
Company payments, 2025
$1,088
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asmita R Patel was code 99214 (office e&m - established), 306 times for 217 patients. In total Asmita R Patel billed 1,107 services in 11 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 306 | 217 | $58.73 | $18K |
| 99214 Office E&M - Established | Office | 196 | 169 | $93.23 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 132 | 124 | $12.81 | $1,691 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 107 | 98 | $12.33 | $1,319 |
| 20610 Joint Injection | Facility | 107 | 47 | $46.98 | $5,027 |
| 99213 Office E&M - Established | Facility | 69 | 32 | $44.63 | $3,079 |
| 99215 Office E&M - Established | Facility | 66 | 53 | $102.48 | $6,763 |
| 99204 Office E&M - New | Facility | 32 | 32 | $91.49 | $2,928 |
| 99215 Office E&M - Established | Office | 24 | 20 | $124.79 | $2,995 |
| 99204 Office E&M - New | Office | 20 | 20 | $115.15 | $2,303 |
| 20600 Joint Injection | Facility | 17 | 11 | $21.92 | $373 |
| 99205 Office E&M - New | Facility | 15 | 15 | $124.44 | $1,867 |
By year: 2022 $205K for 12,992 services; 2023 $110K for 4,517 services; 2024 $65K for 1,107 services.
Medicare prescription drug claims, 2024
In 2024, the drug Asmita R Patel prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 598 prescriptions and refills. In total Asmita R Patel wrote 3,750 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 598 | 1,369 | 169 | $16K |
| Prednisone Generic | 310 | 528 | 149 | $2,052 |
| Hydroxychloroquine Sulfate Generic | 309 | 739 | 87 | $8,982 |
| Gabapentin Generic | 304 | 747 | 112 | $4,682 |
| Enbrel Sureclick Etanercept | 216 | 216 | 31 | $1.6M |
| Leflunomide Generic | 186 | 389 | 53 | $11K |
| Cyltezo(Cf) Pen Adalimumab-Adbm | 124 | 125 | 25 | $796K |
| Alendronate Sodium Generic | 116 | 268 | 40 | $823 |
| Sulfasalazine Generic | 113 | 266 | 35 | $3,903 |
| Folic Acid Generic | 94 | 284 | 40 | $657 |
| Orencia Clickject Abatacept | 92 | 96 | 14 | $524K |
| Allopurinol Generic | 90 | 228 | 29 | $985 |
| Humira(Cf) Pen Adalimumab | 70 | 75 | 19 | $512K |
| Simponi Golimumab | 66 | 73 | 11 | $450K |
| Tizanidine Hcl Generic | 55 | 83 | 23 | $453 |
Brand drugs: - claims; generic drugs: 2,608 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asmita R Patel $1,088 ($1,088 in general payments such as food, travel and fees) from 8 companies. The largest payer was Janssen Biotech, Inc. with $396.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.